Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients

J Dtsch Dermatol Ges. 2023 Jul;21(7):779-784. doi: 10.1111/ddg.15108. Epub 2023 Jun 22.

Authors

Shayan Dasdar¹, Nika Kianfar¹, Soheil Tavakolpour¹, Kamran Balighi¹, Hamidreza Mahmoudi¹, Maryam Daneshpazhooh¹

Affiliation

¹ Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 37345887
DOI: 10.1111/ddg.15108

No abstract available

Publication types

Letter

MeSH terms

Epidermolysis Bullosa Acquisita* / drug therapy
Epidermolysis Bullosa*
Humans
Rituximab / therapeutic use

Substances

Rituximab